•  
  •  
 

Article Type

Original Study

Subject Area

Ear, Nose and Throat

Abstract

Introduction: Otology symptoms can be the presenting complain among patients with temporomandibular joint (TMJ) dysfunction. The ear symptoms related to Temporomandibular joint dysfunction are hearing loss and tinnitus. Tinnitus related to TMJ dysfunction is referred to as a type of somatic tinnitus, and it is caused by a musculoskeletal problem, which should be investigated with different methods of treatment to increase the best efficiency of treatment. Objective: Evaluation of different outcomes of different treatment modalities for patients with tinnitus and TMJ dysfunction by using the advantage of Tinnitus Retraining Therapy versus night guard and medication to determine which of these methods can greatly improve tinnitus symptoms. Methods: The current study was implemented in four groups which consists of control group (group A), which including twenty normal individual with bilateral peripheral normal hearing sensitivity and not complaining from any symptom of TMJ dysfunction or tinnitus and 60 subjects complained of TMJ dysfunction and tinnitus subdivided into three groups where group B comprised of twenty individual treated with Tinnitus Retraining Therapy (TRT), group C contain of twenty subjects treated with placement of night guard and group D comprised of twenty subjects treated with medication. Results: TRT is the best method to improve the perception of the loudness of tinnitus in patients with TMJ dysfunction. Conclusion: TRT and medication are the most sensitive procedure in management of patients complaining of tinnitus and TMJ dysfunction, and they're able to minimize the perception of tinnitus loudness in these patients.

IRB Number

IHS00053

Keywords

Temporomandibular dysfunction, tinnitus, Tinnitus Retraining Therapy (TRT) of somatic tinnitus, Medication in tinnitus .

Creative Commons License

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.

Share

COinS